TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 72 filers reported holding TRINITY BIOTECH PLC in Q4 2016. The put-call ratio across all filers is 55.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $8,452,000 | -14.0% | 1,418,125 | -0.2% | 0.01% | -12.5% |
| Q4 2016 | $9,830,000 | -47.9% | 1,420,529 | -0.5% | 0.01% | -50.0% |
| Q3 2016 | $18,880,000 | +16.3% | 1,428,127 | -0.3% | 0.02% | +14.3% |
| Q2 2016 | $16,240,000 | -1.5% | 1,432,059 | +1.3% | 0.01% | 0.0% |
| Q1 2016 | $16,489,000 | -1.9% | 1,414,119 | -1.1% | 0.01% | 0.0% |
| Q4 2015 | $16,813,000 | -36.0% | 1,429,681 | -37.7% | 0.01% | +16.7% |
| Q3 2015 | $26,264,000 | +177.0% | 2,295,878 | +337.3% | 0.01% | +50.0% |
| Q2 2015 | $9,482,000 | – | 525,010 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
| Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
| Centaur Capital | 135,000 | $2,599,000 | 3.61% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
| Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
| RK Capital | 601,672 | $11,582,000 | 2.31% |
| Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
| KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
| Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
| Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |